In this paper we describe the hitherto unravelled facts on the interactions of a cold atmospheric plasma with living cells and tissues. A specially designed source, plasma needle, is a low-power discharge, which operates under the threshold of tissue damage. When applied properly, the needle does not cause fatal cell injury which would result in cell death (necrosis). Instead, it allows precise and localized cell removal by means of the so-called cell detachment. In addition, plasma can be used for bacterial disinfection. Because of mild treatment conditions, plasma disinfection can be performed in vivo, e.g. on wounds and dental cavities. Presently, one strives to obtain a better control of the operating device. Therefore, plasma has been characterized using a variety of diagnostics, and a smart system has been designed for the positioning of the device with respect to the treated surface.
Introduction
Plasma created by a well-localized electric discharge allows an accurately controlled dosage of active particles and energy to the surface. This feature has led to an enormous success of plasma techniques in solid state surface processing. Now it is possible to profit from the knowledge that has been laboriously gathered in decades of studies on plasma-surface interactions and to identify another application area of plasma technology.
Gas plasma treatment is not completely unknown in medical sciences. The hot plasma coagulation technique arises directly from electro-surgery, and various coagulation units have been designed and commercialized [1] [2] [3] . For example, a hot ionized argon jet, developed by the company ERBE-MED, is successfully applied for non-contact coagulation of wounds and non-specific tissue removal [1] . The main role of plasma in this technique is to supply thermal energy (heat) that will denaturate and desiccate the bleeding tissue. A somewhat less mighty (colder) discharge, created in vaporized physiological fluid, is also used in a variety of surgical procedures [4] . Recently, the biomedical team at the Eindhoven University of Technology has introduced another concept of in vivo plasma treatment, which intentionally makes use of the nonequilibrium properties of plasma. The aim is not to denaturate the tissue but to operate under the threshold of thermal damage and to chemically induce a specific response or modification. A suitable plasma device (plasma needle) has been invented, characterized by means of various plasma diagnostic methods [5] [6] [7] and tested ex vivo on cultured cells [8, 9] and isolated tissues. When operated properly, the plasma remains at room temperature. The effects of treatment are thus not due to heat but to active species (mainly oxygen/hydroxyl radicals and nitric oxide) generated in the plasma or in the tissue that is brought into contact with the plasma. Plasma treatment offers the possibility of modifying tissues at the cellular level, of removing diseased sections without inflammation and damage and of suppressing infections. Such finesse and precision can never be thought of in conventional or laser surgery. Plasma treatment may become a powerful healing technique in the future; however, a number of technical and scientific issues must be tackled before this device is ready for use in the operation theatre or dental clinic. In this work some findings on plasma interactions with living tissues will be surveyed and the latest developments in the instrumentation will be presented. At the moment the most urgent issue is the automatic control of the plasma device. Since the effects of plasma treatment are strongly dependent on the applied conditions, it is essential to monitor and adjust the relevant plasma parameters during treatment. This will not only assure a reliable and reproducible result of the therapy but will also greatly facilitate the work of a physician.
The experiment

Plasma needle
Plasma needles can be operated in various configurations, all of them consisting of a metal wire electrode with a typical length of 5 cm, connected to the RF signal with a frequency around 10 MHz. The needle is placed in a casing, supplied with a gas throughput, mainly helium, at variable flow rates (0-2 l min −1 ) regulated by a mass flow controller of the Brooks series 5850E. In all cases, plasma generation is achieved using a waveform generator Hewlett Packard 33120A and an RF amplifier Amplifier Research 75AP250RF. The power is monitored using a dual directional coupler and an Amplifier Research PM 2002 power meter. The power meter is placed in between the amplifier and the matching network to measure forward and reflected power. The matching network is a home-built λ-type one; a detailed description of its electrical properties is given by Kieft et al [6] . A good tuning of the circuit to resonance is crucial for plasma operation: the network must increase the output voltage from the amplifier (20-30 V) to at least 200 V at the needle; when well-tuned, the reflected power should be reduced to less than 1% of the forwarded value. The voltage at the needle is measured using a voltage probe P6150A from Tektronix, inserted in the electric throughput of the needle. The probe is a 1000 times attenuator with 100 M resistance and 3 pF capacitance.
The prototype was a closed co-axial model with a 1 mm thick needle inserted in a grounded metal tube (1 cm inner diameter), filled with flowing helium and other gases [5] . It had limited (only frontal) optical access through a quartz window closing the tube, and there were no facilities for sample treatment. This configuration was mainly used for the physical characterization of the source in terms of voltage, power, gas temperature and a range of conditions in which a stable glow can be sustained.
Treatment of living cells was for the first time realized in a box configuration, with a thinner (0.3 mm) needle and adjustable needle-to-ground distance [8] . At present, the plasma is produced in a flexible, hand-held device made of metal and plastic. The needle has a diameter of 0.3 mm and is inserted in a Perspex tube with inner diameter 0.8 cm. The length of this 'plasma pen' is about 10 cm. The plasma is generated at the end of the needle at a fixed frequency of 13.56 MHz RF. A schematic drawing and a picture of the plasma device are shown in figure 1.
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Biological samples
Interactions of the cold plasma with living biological samples have been studied on numerous test objects. Primarily, the aim was to unravel basic responses of living cells exposed to a chemically active plasma medium. The following kinds of cultured eukaryotic cells and bacteria have been used: -fibroblasts: chinese hamster ovarian cells (CHO-K1) [8] , 3T3 mouse fibroblasts, -muscle cells: rat aortic smooth muscle cells (SMC) (A7r5) [9] , -endothelial cells: bovine aortic endothelial cells (BAEC) [9] , -epithelial cells: human MR65 cells originating from nonsmall cell lung carcinoma (NSCLC) [10] , -gram-positive bacteria: Streptococcus Mutans, a microorganism present in the oral flora (responsible for dental caries) and -gram-negative bacteria: Escherichia Coli, enteropathogenic species (causes food poisoning) [11, 12] .
In the beginning of this project, we investigated the reactions of simple samples, which contained only one type of cells or bacteria. However, such studies do not provide the full information about the response of a living organism. The final application of the plasma will be the treatment of living human tissues; however their complexity makes the results difficult to predict. Therefore, in the first stage it is advisable to investigate a well-defined and reproducible tissue sample. We have chosen an artery section obtained from a Swiss mouse (carotid and uterine arteries). Arterial tissue has been elaborately described in scientific literature, especially in relation to studies on atherosclerosis [13] . Therefore, the structure of this blood vessel and the responses of the tissue to various damage factors are well known. The structure of a mouse artery is relatively simple; it is thin (lumen diameter ∼300 µm) and has only few cell layers. However, it is a good example to study because it contains all essential elements which constitute other tissues. The outer part (tunica adventitia) is a layer of connective tissue, containing collagen and fibroblast cells, the middle part (media) is a layer of SMC reinforced with elastin fibres and the inner part (intima) is a layer of endothelial cells and subendothelial connective tissue.
In the study of cell reactions in the culture and arterial tissue, various basic assays were applied. Fluorescent staining was used to visualize certain parts/constituents of the cell or to detect a certain process. The principle is the same as in a popular plasma diagnostics, the laser-induced fluorescence: fluorescent products can be illuminated by a laser or a lamp and their broad-band emission can be collected using appropriate filters. In our case, stained cells were observed under a confocal laser microscope, two-photon laser fluorescence microscope or micro-plate reader. The latter is an automated device to record space-averaged fluorescence from the whole cell sample (one well in a multi-well array); it is equipped with a lamp and a set of filters. The information is by far not so detailed as the one provided by microscopy, but one can obtain quantitative data very fast. Micro-plate reader is ideal for parameter scans and in cases when large numbers of experimental points are required for statistics.
The simplest and most powerful diagnostic method is the viability assay: cell tracker green (CTG) or SYTO 13 and propidium iodide (PI). CTG reacts with cytoplasm thiols in a glutathione S-transferase mediated reaction and is converted into a cell-impermeant fluorescent product. During normal cell functioning, thiol levels are high and glutathione S-transferase is abundant; the cells stain bright green. Reduction in CTG emission in comparison with control samples can be due to reduction in living cell population (cell death) and/or to decrease in enzymatic activity in the living cells. In contrast to CTG, SYTO 13 does not provide information about cell activity. It passes through the membrane and stains DNA and RNA in both dead and alive cells with a blue fluorescent marker. Thus, SYTO 13 can be used to determine the total number of cells regardless of their condition. PI is a specific stain to detect dead cells. Similarly to SYTO 13, PI binds to the DNA and RNA and turns into a red fluorescent product, but since it is a membrane-impermeant molecule, it can penetrate only into cells with damaged membranes. As explained in the results section, membrane-permeable cells are dead (necrotic). Furthermore, dual staining SYTO 13 + PI allows us to count dead and alive cells separately because PI binds to nucleic acids stronger than SYTO 13; so necrotic cells would display only red PI fluorescence, while alive ones would remain green. More information on these assays can be found in http://www.probes.com.
Next to viability assays, other stains can be used. For example, in this work programmed cell death (apoptosis) was detected using the M30 antibody, a stain that binds to a caspase-cleaved cytoskeletal protein. Furthermore, extracellular matrix in arterial samples was visualized using eosin.
Fluorescent staining can be also used to assess bacterial viability. Popular fluorescent viability kits contain SYTO 9 (green) and PI and they are applied in a similar way as SYTO 13 and PI on eukaryotic cells. However, for bacteria there are other methods, which may save time and equipment costs. These are overnight incubation of the treated samples and the counting of colony forming units, simple visual observation of the thickness of bacterial film and measurements of visible light absorption. These techniques do not involve fluorescence, so they do not require the usage of powerful light sources and costly optical imaging systems. In this work mainly simple visual methods were used, and they proved to be quite efficient in studying bacterial inactivation.
Positioning control
In pursuit of improving the precision and expanding the application area of plasma treatment, a reliable control system to operate the device must be designed. The urgency of this issue follows from the recent experiments. Avoiding damage of arterial tissue and inducing specific cell responses require a high degree of precision in the positioning of the plasma needle and timing of the treatment. In the case of real medical treatment, there is an additional complication due to an irregular shape of the tissue and movement of the patient. It will also be necessary to take into account the local geometry (curvature) of the tissue surface, to provide even treatment and to avoid accidental short circuits that may be fatal to the cells. The first step in the designing of such a positioning system is the determination of the distance between the needle tip and the sample. During treatment of cells and arterial sections, the distance is usually 1-2 mm, dependent on plasma conditions and the desired effect. It is necessary to maintain this distance constant with at least 10% accuracy. For vulnerable tissues, a higher accuracy will be required. In practice, it means that the positioning sensor will have to track displacements of less than 0.1 mm. Furthermore, one must keep in mind that it will not always be possible to view the treated spot-some operations will be made internally and it is often not feasible to apply an additional endoscope.
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The most natural and elegant solution to the positioning problem would be to make use of a certain plasma parameter that is sensitive to needle displacements. This parameter is easily identified in preliminary experiments: the power consumed in the plasma depends on the distance between the needle and the surface. When the parameters (capacitance and inductance) of the matching network are fixed for a given position, the change in the position causes detuning of the circuit, which is seen as an increase in the reflected power. As will be shown further in the results section, the precision of this natural positioning probe is quite satisfactory for most (medical) applications.
Results and discussion
General appearance and properties of plasma
Plasma needle is a typical atmospheric capacitively coupled micro-discharge.
The visual appearance (size, shape, brightness) and the electrical and thermal properties of the plasma are strongly dependent on the configuration. The crucial parameters that determine the plasma performance are electrode gap (distance from the needle to the grounded object), needle thickness and the feed gas composition. In table 1 some facts on various needle arrangements are summarized. One can generalize that thin and sharp needle electrodes produce small glows, which are stable and easy to ignite at relatively low voltages. This is not surprising because plasma ignition requires a certain electric field strength, and for a sharp needle, this critical field can be realized at a lower input voltage. Small glows (<1 mm in diameter) consume very little power and maintain a low gas temperature [5] . From the medical point of view their properties are very suitable because in tissue treatment it is required that the gas temperature should not exceed the body temperature. Furthermore, a small glow size offers a better precision of the treatment, the latter being of particular importance in micro-surgery. However, it was also observed that small, low power glows cannot be operated in certain gas mixtures, e.g. in the presence of electronegative gases (air). Plasma needle will ignite in air, but it requires a much higher voltage (>600 V) and power input (several watts). An increase in power input does not generally lead to drastic changes in essential plasma parameters such as electron temperature and density. Kieft et al [6] characterized the electrical features of the flexible plasma pen. Typical voltage-power dependence for this device is given in figure 2 . Furthermore, they investigated other plasma properties such as the glow size and charge density. It must be noted that electron density measurement in small-sized, low-density plasmas is generally a difficult task. Most available methods have a too low spatial resolution (interferometry), are too intrusive (probes) and are sensitive to stray light (Thomson scattering) or insensitive to low charge densities (Stark broadening). Thus, in the case of the plasma needle an indirect method was applied. Plasma impedance (Z = Z r + iZ i ) was determined from the voltage-power characteristics supported by a matching network model, and the corresponding conductivity (σ ) was used to estimate the average electron density (n e ):
where e, m e and ν ea are electron charge, mass and collision frequency with neutral gas (relevant for plasmas with low charge density). For the collision frequency, a typical electron temperature of 2 eV was taken and the estimated frequency was 1.6 · 10 12 Hz. The conductivity was obtained from the resistance and typical length scale of the plasma (plasma diameter, determined by visual observation): σ = (Z r L) −1 . Plasma diameter and estimated electron density are plotted in figure 3 as a function of dissipated plasma power. When the power increases, the plasma expands in volume, while the electron density does not change significantly. The magnitude of n e is in very good agreement with theoretical predictions from a fluid code [15] . Optical emission spectroscopy allowed determination of the electron excitation temperature [5] , which also appeared to be approximately constant with power. Electron density and (excitation) temperature are important parameters that condition the plasma activity (excitation, ionization and formation of active radicals). Therefore, one can conclude that atmospheric plasmas operated at higher power do not have a higher activity and efficiency than the low-power ones. A further drawback of increased power is the elevated gas temperature-when the plasma glow expands, cooling by thermal diffusion becomes less efficient and the temperature can reach even a few hundred grades [5] . Thermal damage is one of the most important issues in the treatment of heat-sensitive (biological) objects. Therefore, gas and sample temperatures were extensively studied using various experimental techniques: optical emission spectroscopy [5] , thermocouples [8, 11] , liquid crystal temperature strips [12] and mass spectrometry [16] . The latter is based on the determination of neutral gas density (n) from RGA signals; then, the law p = nk B T is applied assuming constant (atmospheric) pressure. Some typical results are given in figure 4 . The methods for temperature determination are quite different, and they provide different but often complementary information. For example, optical emission is a typical gasphase technique. The data it provides originate from the hottest part of the plasma, the active zone, which yields the highest emission intensity. Therefore, it is not surprising that temperature as high as a few hundreds of degrees is observed ( figure 4(a) ). In contrast, mass spectrometry (figure 4(b)) provides downstream information, as it records the density of gas flowing into the mass spectrometer. The corresponding temperatures are lower. Nevertheless, the trends obtained by various methods are quite consistent. It is evident that gas heating occurs only at high power input; this is also coincident with the increase in the plasma glow size. The thermocouple and the temperature strip are not gas-phase methods. In fact, they are more relevant from the point of view of biomedical applications because they provide information about the heat which the treated object will suffer. From figure 4(c) it follows that the heating of the sample by plasma is usually tolerable. This is because of a large heat capacity of samples: one can treat a living tissue for several seconds or even minutes without inducing thermal damage. Furthermore, figure 4(c) shows that convective cooling is of importance in sustaining a low plasma temperature. In most experiments a gas flow of 2 litre min −1 was used, corresponding with a flow speed of 1.4 m s −1 . However, high flow rates can cause sample desiccation (e.g. in the treatment of vascular tissue); in this case the flow should be reduced.
A general feature of the plasma needle is the existence of two operation modes: the unipolar one, observed when the needle is separated by several millimetres from the ground, and the bipolar one, where plasma is sustained between the needle tip and the ground. The two types of plasma are shown in figure 5 . The transition between the modes is abrupt: when the needle-to-surface gap is brought close to the critical distance (typically 3 mm for 100-300 mW power), the glow suddenly 'leaps' over, expands and increases in brightness. As expected, the bipolar mode is much more effective for the treatment of biological and other samples. Several experiments were conducted to assess plasma activity in both the modes. The results can be summarized as follows:
-Density of active oxygen species, diffusing from the plasma into the liquid medium, decreased drastically with increasing distance from the liquid interface (by a factor S173 Figure 5 . Two modes of plasma operation: left-plasma is concentrated at the needle tip, grounded electrode is remote (at least 3 mm away), right-plasma is in contact with the treated object (dry skin, thus poorly grounded).
of 10 from 1 to 3 mm). The liquid was an aqueous buffered solution in a 96-well plate, placed on a grounded metal stage. These measurements were performed using a fluorescent label probe (CM-H 2 DCFDA) that allows the detection of free oxygen radicals in the fluid with sensitivity in the sub-micromolar range [17] . -The energy flux from the plasma, due to deposition of energetic particles, was almost constant as long as the plasma was in contact with the collecting probe and decreased drastically when the glow was detached from the device's surface. Experiments showed that, in the bipolar mode, practically all input power in the plasma is deposited on the surface. This measurement made use of a calibrated thermal probe (a small metal disc attached to a thermocouple); energy flux from the plasma was calculated from the dynamic temperature changes of the disc [7] . -In mass spectrometric measurements, no ions and radicals were detected when the glow was not in contact with the orifice of the mass spectrometer. The experiment was performed with a new molecular beam mass spectrometer, developed by HIDEN Analytical, especially for the analysis of atmospheric media [16] . -Direct tests on living cells showed no instantaneous effect when the plasma was not in contact with the sample surface. This also served to certify that only gas flow and/or only RF radiation have little or no influence on cells.
Of course, prolonged exposure of samples to flowing helium could cause desiccation, but this effect is of a different nature from plasma-induced cell reactions. -However, the remaining amount of active radical species, present in the remote plasma (afterglow) region, was sufficient to inactivate bacteria. Studies on bactericidal properties of the plasma showed that bacteria that were as far as 1 cm from the needle tip were still destroyed [12] .
The above-mentioned studies showed that the length of the electrode gap, in combination with the applied plasma power, is crucial for the result of plasma treatment. This is the main motivation to construct a fully automated plasma device with a distance sensor and a feedback mechanism for the adjustment of the position.
Treatment of biological samples
In order to be competitive with other techniques (traditional surgery, cauterization, lasers, systemic and topical drugs), plasma must offer some unique possibility of cell and tissue removal and/or manipulation. In refined applications such as micro-surgery, the main drawbacks of existing methods are a lack of precision (it is difficult to address only the selected area) and ubiquitous accidental cell death (necrosis). The latter occurs when the cell membrane ruptures and the cytoplasm is released. This event causes a complex reaction of the organism, known as inflammation. In principle, the organism can cope with inflammation, but it does have its unfavourable consequences. These are tissue damage, swelling, pain, delayed healing, no neat tissue repair (scar formation), etc. So far necrosis was inevitable in any surgical procedure and there was simply no better alternative. However, operating without necrosis and inflammation would be a major improvement in terms of tissue saving, safety and cosmetic effects of treatment. Apparently, plasma treatment can move or dispose cells without necrosis; some facts on living cell responses will be given in section 3.2.1. In addition to high precision and low occurrence of necrosis, plasma treatment is a non-contact method, and non-contact treatment is preferred because of reduced risk of mechanical damage (e.g. vital membrane or blood vessel rupture, sticking of tissue to the surgical device) and secondary bacterial infection. The latter is a major problem in the treatment of wounds with impaired healing, e.g. in chronic wounds and the ones where the whole dermis has been destroyed (third degree burns).
All biological samples, described in this work, were treated with helium plasma at 2 litre min −1 flow-this resulted in a small (0.5%) admixture of air in the noble gas. The reason for applying this composition is a compromise between high helium content (which means a low operating voltage [5] ) and an acceptable flow rate. Helium percentage can be increased by increasing flow rate, but high flows result not only in fast gas consumption but also in sample desiccation. Desiccation of the sample leads to shrinkage of the cells and to cell death by necrosis. This effect must thus be eliminated. The influence of plasma composition on cell reactions and bacterial inactivation has not been studied yet; however, it is expected that small admixtures of specific gases (e.g. N 2 O) may improve the results of treatment.
Cells in culture.
Recently, much effort has been invested in unravelling the principle of plasma action on living tissues. It is agreed that the active species of the plasma (radicals and ions) undergo interactions with living cells and induce specific responses at the cellular level [8] [9] [10] . Since these species are unstable and easily consumed in various reactions, the effects of the plasma treatment are strictly localized. The penetration depth is usually limited to a single cell layer, but it can be extended by prolonging the treatment time. It is not clear whether charged species play a role in plasma-cell interactions. If so, the action of ions should be similar to the one of radicals because ions can produce radicals by dissociating water molecules in the vicinity of the cell. On the other hand, the density of charged species is much lower than that of radicals (10 16 [17] ), so their contribution should be minor. However, if an ion reaches the exposed cell membrane, affects the membrane potential and disturbs the Na-K pump, the result might be fatal for the cell. Therefore, in our experiments cells are always covered with a thin film of liquid medium. The other reason for using this liquid is to prevent cell death by desiccation.
The amount of active species that eventually reaches the cell lies in the physiological range [17] , i.e. it is comparable to the radical concentrations produced by the organism itself during an increased activity (e.g. tissue repair). Henceforth, our hypothesis is that the plasma can operate in a close-to-natural manner: it may regulate cellular processes without inflicting damage and help the organism to dispose of the diseased sections. Two important cell reactions to plasma treatment were identified: temporary loss of cell adhesion (so-called cell detachment) and programmed cell death (apoptosis). Cell detachment is similar to a wellknown chemical effect: applying trypsine to cultured cells also causes loss of cell contact. Trypsine is an enzyme which is always present in the digestion system-it facilitates intake of nutrients by breaking down proteins. When applied to attached cells, trypsine digests the cell adhesion molecules (CAMs). These are trans-membrane proteins that are responsible for cell-cell recognition (cadherins) and cell anchoring in the extracellular matrix or on an artificial scaffold (integrins). In the trypsinized cells the basic phospholipid membrane structure is not digested, so the cells remain alive. Trypsine is only used for research purposes because its working is neither specific nor local; moreover, the extensive/repetitive usage of trypsine leads to cell damage. In contrast to trypsinizing, treatment with the plasma needle allowed very well-localized cell detachment. The cell sample displayed a typical void, which was completely free of cells; the borders were very sharp and distinct ( figure 6 ). The size of the void could be regulated by changing the treatment conditions. For example, a 5 mm void was obtained at treatment time of 10 s [8] at about 100 mW power. The smallest void that was produced hitherto was 100 µm in diameter [8] . However, this is not the limit: if the size of the plasma is further reduced, the precision of treatment might be improved to address only a few cells or even a single cell. In figure 7 the CTG-fluorescence signal is shown in dependence of exposure time. This signal is proportional to the amount of living cells remaining on the sample; its decrease thus reflects the amount of detached cells. In the same experiment no necrosis was observed. When the dose of plasma was very low, corresponding to 1-2 s of treatment at power below 100 mW, voids were not formed anymore. Nevertheless, cell detachment was still visible-the cells assumed a rounded shape, like droplets ( figure 8 ). This means that cell-cell contact was interrupted (cadherins were damaged), while the cells were still attached to the scaffold (integrins remained functional).
Cell detachment is of general nature-it was observed on all studied types of cells: fibroblasts, smooth muscle, endothelial and epithelial cells; the extent of the phenomenon was about the same in all the cases. Detachment appeared to be temporary; the cells restored contact within several hours after exposure to the plasma. This is a typical time scale for synthesis of proteins and repair of minor damage in viable cells. This suggests that plasma does not have a drastic negative effect on cell viability and activity. In fact, under proper treatment S175 conditions (low power) necrosis did not occur at all. Typically, necrotic cells were found in the samples treated at the power of 300 mW and higher. In such cases, necrosis might be caused by heat and/or desiccation.
Cell detachment may be a result of interactions of plasma radicals with the cell membrane: the reactive oxygen species can oxidize and thus break the CAMs. This process need not result in damage to the cell interior. Alternatively, plasma species can act like messengers: they convey certain stimuli, which will alert the cell and trigger a mechanism to move away from a dangerous area. Again, in this process the stimulus remains under the threshold of damage: if the cell can 'escape' on time, it will remain intact. Summarizing, cell detachment is a reversible effect that allows removal or mobilization of cells. The cells remain alive and viable, but the treated part of the tissue can be removed (peeled). This will also enable one to extract cells from the tissue to prepare a native graft. In the absence of necrosis, no inflammation in the body will be induced.
Another 'neat' way of removing cells is the induction of programmed cell death (apoptosis). Apoptosis is an internally released mechanism of cellular self-destruction, which is a response to moderate yet irreversible cell damage. In the organism, this is the normal way of disposing of damaged, old and non-functional cells. The message of death is emitted by the mitochondria, and it initiates a complex chemical process in which the cell is prepared to disappear: the lamina of the nucleus dissolves and the DNA condenses into lumps, the cytoskeleton is broken down, the cell shrinks and its membrane displays blebs. Finally, the cell falls apart in several membrane-bound apoptotic bodies. The membrane also externalizes phosphatidyl serine to attract macrophages that will consume the remains of the cell. Apoptosis can be detected in many ways: by visual observation of the cell shape, by staining of the cell's DNA with PI followed by microscopic detection of condensed DNA pieces, by staining externalized phosphatidyl serine (Annexin V assay), etc. In our case [9] another technique was applied: the M30 antibody which stains the cytoplasm of dying cells. Induction of apoptosis by plasma treatment was feasible but much more difficult than cell detachment. It was also not so easy to reproduce. In the MR65 about 3% of human epithelial cells underwent apoptosis, while 100% were detached (rounded). A typical picture of an apoptotic MR65 cell is shown in figure 9(a) ; a mixture of detached and apoptotic cells can be seen in figure 9(b) . Apparently, induction of apoptosis requires a very accurate dosing: the injury factor must enter the cell, but no permanent membrane damage (necrosis) may occur. The apoptotic trigger factor may be a small, active radical (e.g. O or OH) that can pass through the membrane. Alternatively, reversible membrane poration can be induced and calcium from the solution can penetrate the cell; the latter can induce apoptosis. A good description of various apoptosis-inducing factors can be found in [18] . Our hypothesis is that apoptosis induction by plasma can be improved by applying short pulses with high intensity. This can be realized by maintaining the plasma-sample distance under 1 mm and forwarding high power (>1 W) millisecond-long pulses. It is difficult to perform manually, so it provides another strong motivation for the construction of a fully automated device.
Plasma treatment offers a neat manner of cell removal by detachment and (after optimization) by apoptosis. In both cases the integrity of the cell membrane is not violated, and consequently no inflammatory reaction is expected.
Arterial tissue.
Study of plasma interaction with arterial tissue is still in the preliminary phase. So far, ex vivo treatment of carotid and uterine arteries excised from euthanized mice has been performed [19] . Arteries were mounted in a perfusion reactor and filled with liquid at a transmural pressure of 40 mm Hg. Fluorescent stains and two-photon fluorescence microscopy were applied to visualize fibroblasts in adventitia and SMC in media; eosin was used to stain collagen and elastin. The first outcome was that the transmural pressure remained constant, thus no artery perforation took place. At low plasma powers (100 mW) the effects were only limited to adventitia. Occasional necrosis in fibroblasts was observed, but the collagen matrix was intact. When higher plasma powers (450 mW) were applied, effects extended deeper into the tissue. The collagen structure was damaged and wall thickness was reduced. The plasma effect on collagen was comparable to that induced by heating [20] . A treated sample is shown in figure 10 . In this sample, SMC were damaged. This was indicated by the uptake of eosin by these cells, which does not occur when the cells are healthy. However, one can also see that SMC changed their shape and orientation: from elongated and aligned before to rounded and chaotic after treatment. This might indicate that cell detachment, similar to the one described in section 3.2.1, can also occur in the tissue. Furthermore, some cells exhibited membrane blebbing, which is indicative of apoptosis. In this preliminary work, treatment conditions were too harsh, so that necrosis was abundant. However, in the treatment of atherosclerosis one aims at removing large amounts of tissue, so occasional necrosis should not be a great hindrance. In fact, plaque removal with the needle might be much less destructive and patient-friendly than mechanical methods or laser/spark tissue ablation.
Bacterial inactivation.
Plasma treatment does not only allow us to avoid contamination-in fact, it may actively fight bacterial infection in the organism. Bactericidal properties of many plasma sources are well documented in the literature [21, 22] ; there are no a priori reasons to doubt the efficiency of the plasma needle in killing various pathogenic microorganisms. In vivo bacterial inactivation is one of the great potentials of plasma treatment.
Plasma is a gaseous medium of which one expects a certain ability to penetrate irregular cavities and fissures. This inspired the research on plasma disinfection of dental cavities. Usage of plasma would have many essential advantages. First of all, it would save plenty of healthy dental tissue, which is usually removed by drilling in conventional preparation of cavities. In many cases (e.g. beginning caries) tissue removal is not necessary at all-after disinfection the lesion may cure by itself. Usage of plasma on dental plaque and early caries would greatly improve oral hygiene. Furthermore, plasma treatment is completely painless and free of other discomforts (sound, smell, etc). Finally, the tooth surface after treatment may be particularly active, due to the presence of dangling bonds, adsorbed radicals and oxygen molecules. It is expected that adhesion of restoration material to such prepared surfaces can be improved.
Plasma treatment of caries can become a major innovation in dentistry. However, the effectiveness of our particular plasma device on pathogenic species must be demonstrated first. Therefore, many tests were conducted on various bacterial samples. Escherichia Coli was the first target because this species is easy to culture and is fairly resistant to chemical damage factors. Droplets of bacterial suspension containing 10 7 -10 8 colony forming units in 50 µl fluid were treated at low plasma powers (100 mW), plated out and incubated overnight. The survival curve (number of colonies as a function of treatment time) for this experiment is shown in figure 11 . Because of the substantial thickness of the droplet (1-2 mm), several tens of seconds were needed for deactivation. The so-called D-value, the time required to deactivate one decade (90%) of the bacteria, was about 40 s. When thinner samples were treated, deactivation times were substantially shorter. Treatment of thin (0.1 mm) E. Coli films grown on Petri dishes resulted in the fast formation of characteristic circular voids at the incidence of the plasma needle ( figure 12 ). The voids, up to 1 cm in diameter, were completely free of bacteria, while the adjacent regions were not influenced-the void borders were sharp. These empty areas are of different nature from the voids induced in mammalian cell culture (section 3.2.1). In the previous case the cells were detached and rinsed away; for bacteria, no rinsing was applied and the micro-organisms could not migrate. Thus, bacteria within the voids were destroyed, and one could easily determine the number of dead bacteria by a visual estimation of the void size. It was argued that bacterial destruction is caused by short-living plasma species and not, for example, by heat. A parameter study was conducted to relate the amount of killed bacteria to plasma power, exposure time and needle-to-sample distance. The aim of this study was to optimize the conditions for real in vivo treatment. Figure 13 shows the void sizes and corresponding numbers of destroyed bacteria as a function of treatment time. One can see that the curves saturate; a similar effect was observed when plasma power was increased-the void reached a certain size and did not increase anymore. Thus, the usage of high powers and prolongation of treatment time is not necessary because it does not improve the efficiency of disinfection. Furthermore, plasma treatment was effective even at quite long needle-tosample distance: voids were induced even at 8 mm away from the needle. These findings are very encouraging for in vivo applications, where one strives to use low powers and large distances to suppress thermal effects.
At present, deactivation of Streptococcus Mutans is investigated [23] . S. Mutans is the actual species that causes dental caries. Similarly to the pilot study on E. Coli, biofilms are treated. However, in the case of S. Mutans it is possible to grow films of different thicknesses, even up to 5 mm thick. Survival of S. Mutans after plasma exposure is assayed using fluorescent viability kits; the areas that can be freed from bacteria are similar to the case of E. Coli.
Concluding, bacterial inactivation by the plasma needle seems to be satisfactory: it is reasonably fast and it requires mild treatment conditions, for which no thermal damage to the organism would occur. Regarding that for most in vivo applications (dental cavities, wounds) it is required to reduce only 99% of the bacteria, one can state that plasma needle treatment is suitable for disinfection.
Smart positioning sensor
The hitherto conducted studies have shown that the induction of therapeutically useful cell reactions requires extremely careful dosage of plasma treatment. Plasma power, distance between the needle and the tissue and exposure time are essential for the result. For example, cell detachment occurs at 1-2 mm and bacterial disinfection at up to 10 mm; this distance should be maintained during seconds/minutes of treatment with an accuracy of about 10%. Induction of apoptosis requires more precision in positioning and timing: the cells must be exposed at a shorter distance (<1 mm), while the treatment time must be in the sub-second range. In the case of in vivo applications, additional complications arise: living tissues have an uneven surface structure and they may move during operation. Thus, the construction of an automated plasma device conditions the further development of plasma surgery. This device should be able to maintain a constant distance to uneven (threedimensional) surfaces, perform surface scanning at a constant (regulated) speed, so that all processed sectors receive the same dosage. Moreover, it should be correct for the motion of The first step in tackling this problem is obtaining a good control of the gap width (needle-to-sample distance). It appears that this distance (d) can be monitored using only the intrinsic properties of the plasma. This is because the electrode gap determines the local electric field (E). At an imposed (radio-frequency) voltage V , the field scales approximately as V /d. The electric field determines the ionization rate, electron/ion densities, conductivity σ and eventually the power consumption in the plasma (P = σ E 2 ). It is observed that the power increases rapidly at short distances. Thus, a well-defined relation between the distance and the power may become the basis of the smart positioning sensor. The sensor works for various sorts of surfaces. The powerdistance dependence is strongest when the needle approaches a conductive grounded surface, but semi-floating, poorly conducting samples can be used as well. In figure 14 a typical curve is shown for a plastic Petri dish filled with agar (for bacterial cultures).
The proposed sensor should work as follows: the needle tip is placed at the desired distance from the surface and moved along a predefined path in the xy-plane. If the surface is not smooth, the gap width will vary and discharge characteristics will change. The setup is equipped with a high-quality, lowloss matching network that minimizes the reflected power [5] .
Variation in the electrode gap will cause detuning and an attendant change in the reflected power. The latter can be measured very accurately and used for automatic distance adjustment. Feedback control is usually very effective: it stabilizes a system, has a linearizing effect on the input-output mapping, gives robustness with respect to system uncertainty and attenuates external disturbances on the output [24] . A general feedback diagram is given in figure 15 . Here, the process represents the needle dynamics with its position as output. The actuator translates current from the controller into force on the needle. Variations in gap width are the disturbance on the measured output. The sensor system transforms this output to the reflected power signal, which is compared with the initial signal, at t = 0. From the difference (error) a control algorithm calculates the input to the actuator and closes the loop. To be able to design the control algorithm, dynamic behaviour of the sensor and plant must be identified. Frequency response measurements are widely used to identify and design dynamical systems. A frequency response function is the forced response of the system to the sinusoidal excitation with a given frequency. In our case, the plasma needle was fixed at a certain distance from an electrically conducting sample, and the latter was forced to oscillate by a voice coil actuator. The actual movement was tracked by a laser vibrometer. Then, coherence was determined between the vibrometer and plasma reflected power signals, to indicate the amount of signal strength of the input that is present in the output signal. This coherence should be at least 95% to assure a proper dynamic behaviour. Coherence plots, taken at two different initial gap widths, are shown in figure 16 . It is seen that the behaviour at short gap widths is very good: the coherence is high and the noise is low; the disturbance at very low frequency is of no concern. Thus, a good control of the needle position is feasible. At larger distances (4-5 mm) the performance is clearly worse. Lack of coherence at large gap widths is not necessarily a hindrance because the distance of 1-2 mm is anyway most interesting from the point of view of medical applications. Larger distances are less effective; they will be rarely used and a good positioning control will not be so necessary. Finally, it was found that the smart positioning sensor based on the reflected power allows tracking S179 of displacements as small as 0.1% of the initial d value. This accuracy is more than sufficient.
Conclusion
Recent years have brought substantial progress in the laborious process of preparing a new medical technique. The plasma device is under control and the instrumentation has been greatly improved. Studies on cultured cells and tissues provided many findings, which are both fundamentally interesting and potentially applicable in health care. What will be the major application area of cold plasma surgery? Will it be dentistry, wound healing, dermatology, cosmetics, internal (small scale) surgery, cellular modification in cell biology and related sciences or all of these? This question must be answered in the future, but we are sure that cold plasma will appear in medical procedures where high precision, minimum destruction and finesse in operation are required.
